Shire's ADHD drug succeeds in trial to treat binge eating

LONDON (Reuters) - Pharmaceutical group Shire PLC said Vyvanse, its amphetamine-based drug prescribed to U.S. students to control ADHD, had also been successful in treating the newly-recognized binge eating disorder (BED) in a trial.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news